InnovAge Holding Corp. announced on September 22, 2026, that it has entered into an underwriting agreement regarding the sale of its common stock. The transaction involves the Company’s selling shareholder, who has agreed to sell an aggregate of 10,000,000 shares of common stock to a group of underwriters.
The shares are being sold at a price of $9.25 per share. The underwriters named in the agreement are Barclays Capital Inc., Goldman Sachs & Co. LLC, and Wells Fargo Securities, LLC. In addition to the firm shares, the underwriters have been granted an option to purchase up to an additional 1,500,000 shares of common stock within a 30-day period following the agreement date.
According to the filing, InnovAge Holding Corp. will not receive any proceeds from the sale of these shares. The transaction is registered under the Securities Act of 1933 pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-297888). The shares were delivered against payment on September 24, 2026.
